Brind.

YD Bio Limited has established its headquarters in Taipei and is currently conducting clinical trials in Canada.

Steady: 1 in the last 7 days Updated tuesday

The latest in this situation

  1. The collaboration between YD Bio and EG BioMed expanded to include JoiiUp for AI Assessment.
  2. YD Bio Limited and EG BioMed Co., Ltd. collaborated on the launch of an AI Cancer Risk Assessment.

How it started

1 report, 1 independent, last reported Jun 30. The briefing below covers this first event.

AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.

What happened

Some supportReported by 1 outlet

YD Bio Limited has established its headquarters in Taipei and is currently conducting clinical trials in Canada.

Who's involved

What this event is mainly about
Taipei

How it developed

Newest first. Tap a step to see who reported it.
  1. YD Bio Limited and EG BioMed Co., Ltd. collaborated on the launch of an AI Cancer Risk Assessment.Sub-event
  2. YD Bio Limited is conducting clinical trials in Canada, with its headquarters in Taipei.1 source

Keep exploring

The entities involved

Coverage

Newest first; wire copies grouped